Shopping Cart
- Remove All
- Your shopping cart is currently empty
ALK4290 (AKST4290) is a potent, orally active CCR3 inhibitor (compound Example 2) with a Ki of 3.2 nM for hCCR3[1], suitable for research into neovascular age-related macular degeneration and Parkinsonism[2][3].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,520 | 6-8 weeks | |
50 mg | $1,980 | 6-8 weeks | |
100 mg | $2,500 | 6-8 weeks |
Description | ALK4290 (AKST4290) is a potent, orally active CCR3 inhibitor (compound Example 2) with a Ki of 3.2 nM for hCCR3[1], suitable for research into neovascular age-related macular degeneration and Parkinsonism[2][3]. |
Targets&IC50 | CCR3:3.2 nM (Ki) |
Alias | ALK4290 |
Molecular Weight | 512.04 |
Formula | C27H34ClN5O3 |
Cas No. | 1251528-23-0 |
Relative Density. | 1.288 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.